Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Smadja

Showing results (221-230 of 225) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 225 results.
Nature Communications|November 27, 2023
Author Correction: Elevated plasma complement factor H related 5 protein is associated with venous thromboembolismMaria Jesus Iglesias, Laura Sanchez-Rivera, Manal Ibrahim-Kosta, et al.
Scientific Reports|April 24, 2025
sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trialDavid M Smadja, Clément R Massonnaud, Aurélien Philippe, et al.
American Journal of Human Genetics|March 17, 2015
Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolismMarine Germain, Daniel I Chasman, Hugoline de Haan, et al.
Circulation|September 26, 2022
Cross-Ancestry Investigation of Venous Thromboembolism Genomic PredictorsFlorian Thibord, Derek Klarin, Jennifer A Brody, et al.
Science (New York, N.Y.)|September 25, 2020
Autoantibodies against type I IFNs in patients with life-threatening COVID-19Paul Bastard, Lindsey B Rosen, Qian Zhang, et al.
Pageof 23

Showing results (221-230 of 225) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 225 results.
Nature Communications|November 27, 2023
Author Correction: Elevated plasma complement factor H related 5 protein is associated with venous thromboembolismMaria Jesus Iglesias, Laura Sanchez-Rivera, Manal Ibrahim-Kosta, et al.
Scientific Reports|April 24, 2025
sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trialDavid M Smadja, Clément R Massonnaud, Aurélien Philippe, et al.
American Journal of Human Genetics|March 17, 2015
Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolismMarine Germain, Daniel I Chasman, Hugoline de Haan, et al.
Circulation|September 26, 2022
Cross-Ancestry Investigation of Venous Thromboembolism Genomic PredictorsFlorian Thibord, Derek Klarin, Jennifer A Brody, et al.
Science (New York, N.Y.)|September 25, 2020
Autoantibodies against type I IFNs in patients with life-threatening COVID-19Paul Bastard, Lindsey B Rosen, Qian Zhang, et al.
Pageof 23